This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tan, Y.-J. Articles by Hong, W. Search for Related Content PubMed PubMed Citation Articles by Tan, Y.-J. Articles by Hong, W.

Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers

Yee-Joo Tan,^1,* Phuay-Yee Goh,^1, Burtram C. Fielding,¹ Shuo Shen,¹ Chih-Fong Chou,¹ Jian-Lin Fu,¹ Hoe Nam Leong,² Yee Sin Leo,² Eng Eong Ooi,³ Ai Ee Ling,⁴ Seng Gee Lim,^1, and Wanjin Hong^1,

Institute of Molecular and Cell Biology,¹ Tan Tock Seng Hospital,² Environmental Health Institute, National Environmental Agency,³ Virology Section, Department of Pathology, Singapore General Hospital,Singapore, Republic of Singapore⁴

Received 29 September 2003/ Returned for modification 24 November 2003/ Accepted 22 December 2003

A new coronavirus (severe acute respiratory syndrome coronavirus [SARS-CoV]) has been identified to be the etiological agent of severe acute respiratory syndrome. Given the highly contagious and acute nature of the disease, there is an urgent need for the development of diagnostic assays that can detect SARS-CoV infection. For determination of which of the viral proteins encoded by the SARS-CoV genome may be exploited as diagnostic antigens for serological assays, the viral proteins were expressed individually in mammalian and/or bacterial cells and tested for reactivity with sera from SARS-CoV-infected patients by Western blot analysis. A total of 81 sera, including 67 from convalescent patients and seven pairs from two time points of infection, were analyzed, and all showed immunoreactivity towards the nucleocapsid protein (N). Sera from some of the patients also showed immunoreactivity to U274 (59 of 81 [73%]), a protein that is unique to SARS-CoV. In addition, all of the convalescent-phase sera showed immunoreactivity to the spike (S) protein when analyzed by an immunofluorescence method utilizing mammalian cells stably expressing S. However, samples from the acute phase (2 to 9 days after the onset of illness) did not react with S, suggesting that antibodies to N may appear earlier than antibodies to S. Alternatively, this could be due to the difference in the sensitivities of the two methods. The immunoreactivities to these recombinant viral proteins are highly specific, as sera from 100 healthy donors did not react with any of them. These results suggest that recombinant N, S, and U274 proteins may be used as antigens for the development of serological assays for SARS-CoV.

Y.-J.T. and P.-Y.G. contributed equally to this study.

S.G.L. and W.H. were both senior authors for this paper.

This article has been cited by other articles:

• Zhong, X., Guo, Z., Yang, H., Peng, L., Xie, Y., Wong, T.-Y., Lai, S.-T., Guo, Z. (2006). Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients. J. Gen. Virol. 87: 369-373 [Abstract] [Full Text]  
• Huang, C., Narayanan, K., Ito, N., Peters, C. J., Makino, S. (2006). Severe Acute Respiratory Syndrome Coronavirus 3a Protein Is Released in Membranous Structures from 3a Protein-Expressing Cells and Infected Cells. J. Virol. 80: 210-217 [Abstract] [Full Text]  
• Liang, Y., Wan, Y., Qiu, L.-w., Zhou, J., Ni, B., Guo, B., Zou, Q., Zou, L., Zhou, W., Jia, Z., Che, X.-y., Wu, Y. (2005). Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS. Clin. Chem. 51: 1382-1396 [Abstract] [Full Text]  
• Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Tsoi, H.-w., Fung, A. M. Y., Kao, R. Y. T., Chan, K.-h., Peiris, J. S. M., Yuen, K.-y. (2005). Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus Pneumonia. J. Clin. Microbiol. 43: 3054-3058 [Abstract] [Full Text]  
• Keng, C.-T., Zhang, A., Shen, S., Lip, K.-M., Fielding, B. C., Tan, T. H. P., Chou, C.-F., Loh, C. B., Wang, S., Fu, J., Yang, X., Lim, S. G., Hong, W., Tan, Y.-J. (2005). Amino Acids 1055 to 1192 in the S2 Region of Severe Acute Respiratory Syndrome Coronavirus S Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents. J. Virol. 79: 3289-3296 [Abstract] [Full Text]  
• Tan, Y.-J., Fielding, B. C., Goh, P.-Y., Shen, S., Tan, T. H. P., Lim, S. G., Hong, W. (2004). Overexpression of 7a, a Protein Specifically Encoded by the Severe Acute Respiratory Syndrome Coronavirus, Induces Apoptosis via a Caspase-Dependent Pathway. J. Virol. 78: 14043-14047 [Abstract] [Full Text]  
• Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Chan, K.-H., Hui, W.-T., Kwan, G. S. W., Peiris, J. S. M., Couch, R. B., Yuen, K.-Y. (2004). False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-CoV Spike Polypeptide. J. Clin. Microbiol. 42: 5885-5888 [Abstract] [Full Text]  
• Guan, M., Chen, H. Y., Tan, P. H., Shen, S., Goh, P.-Y., Tan, Y.-J., Pang, P. H., Lu, Y., Fong, P. Y., Chin, D. (2004). Use of Viral Lysate Antigen Combined with Recombinant Protein in Western Immunoblot Assay as Confirmatory Test for Serodiagnosis of Severe Acute Respiratory Syndrome. CVI 11: 1148-1153 [Abstract] [Full Text]  
• Guan, M., Chen, H. Y., Foo, S. Y., Tan, Y.-J., Goh, P.-Y., Wee, S. H. (2004). Recombinant Protein-Based Enzyme-Linked Immunosorbent Assay and Immunochromatographic Tests for Detection of Immunoglobulin G Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus in SARS Patients. CVI 11: 287-291 [Abstract] [Full Text]